Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
OtherResearch

Development of Protein-Like Reference Material for Semi-Quantitatively Monitoring Visible Proteinaceous Particles in Biotherapeutics

Srivalli N Telikepalli, Kristen Gonzalez, Sonia Dragulin-Otto, Dean Ripple, Michael J. Carrier and Mariam Khan
PDA Journal of Pharmaceutical Science and Technology June 2019, pdajpst.2018.008953; DOI: https://doi.org/10.5731/pdajpst.2018.008953
Srivalli N Telikepalli
1 National Institute of Standards and Technology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: snt2@nist.gov
Kristen Gonzalez
2 MedImmune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gonzalezk@medimmune.com
Sonia Dragulin-Otto
2 MedImmune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dragulin-ottos@medimmune.com
Dean Ripple
1 National Institute of Standards and Technology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dean.ripple@nist.gov
Michael J. Carrier
1 National Institute of Standards and Technology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: michael.carrier@nist.gov
Mariam Khan
2 MedImmune
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: khanma@medimmune.com
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

pdajpst.2018.008953
DOI 
https://doi.org/10.5731/pdajpst.2018.008953
PubMed 
31209163

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Received May 10, 2018
  • Accepted February 27, 2019
  • Published online June 17, 2019.

Article Versions

  • You are currently viewing a previous version of this article (June 17, 2019 - 04:45).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2019, Parenteral Drug Association

Author Information

  1. Srivalli N Telikepalli1,3 (snt2{at}nist.gov),
  2. Kristen Gonzalez2 (gonzalezk{at}medimmune.com),
  3. Sonia Dragulin-Otto2 (dragulin-ottos{at}medimmune.com),
  4. Dean Ripple1 (dean.ripple{at}nist.gov),
  5. Michael J. Carrier1 (michael.carrier{at}nist.gov) and
  6. Mariam Khan2 (khanma{at}medimmune.com)
  1. 1 National Institute of Standards and Technology;
  2. 2 MedImmune
  1. ↵* Corresponding author; email: snt2{at}nist.gov

Cited By...

  • 9 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Machine learning approaches to root cause analysis, characterization, and monitoring of subvisible particles in monoclonal antibody formulations
    David N. Greenblott, Jingtao Zhang, Christopher P. Calderon, Theodore W. Randolph
    Biotechnology and Bioengineering 2022 119 12
  • Monitoring of Visible Particles in Parenteral Products by Manual Visual Inspection—Reassessing Size Threshold and Other Particle Characteristics that Define Particle Visibility
    Maryam Mazaheri, Miguel Saggu, Klaus Wuchner, Atanas V. Koulov, Felix Nikels, Pascal Chalus, Tapan K. Das, Patricia W. Cash, Christof Finkler, Sophia V. Levitskaya-Seaman, John Case, Jonny Parsons, Kristen Gonzalez
    Journal of Pharmaceutical Sciences 2024 113 3
  • Recent Achievements and Current Interests in Research on the Characterization and Quality Control of Biopharmaceuticals in Japan
    Akiko Ishii-Watabe, Hiroko Shibata, Hiroyuki Suetomo, Yosuke Ikeda, Srivalli Telikepalli, Masato Kiyoshi, Yu Hayashi, Takashi Muto, Yukako Tanaka, Satomi Ueda, Takafumi Iwura, Satoshi Saitoh, Michihiko Aoyama, Akira Harazono, Masashi Hyuga, Yukihiro Goda, Tetsuo Torisu, Susumu Uchiyama
    Journal of Pharmaceutical Sciences 2020 109 5
  • An Interlaboratory Study to Identify Potential Visible Protein-Like Particle Standards
    Srivalli N. Telikepalli, Michael J. Carrier, Dean C. Ripple, Greg Barnett, Ashwinkumar Bhirde, Donna Bolton, George M. Bou-Assaf, Erica Ferrari, Scott Leigh, Sophia Levitskaya-Seaman, Tim Menzen, Felix Nikels, Anna Riley, Miguel Saggu, Neha Sahni, Eric Vernooij, Klaus Wuchner
    AAPS PharmSciTech 2022 24 1
  • Supervised and unsupervised machine learning approaches for monitoring subvisible particles within an aluminum‐salt adjuvanted vaccine formulation
    David N. Greenblott, Caitlin V. Wood, Jingtao Zhang, Nelia Viza, Ramesh Chintala, Christopher P. Calderon, Theodore W. Randolph
    Biotechnology and Bioengineering 2024 121 5
  • Features in Backgrounds of Microscopy Images Introduce Biases in Machine Learning Analyses
    David N. Greenblott, Florian Johann, Jared R. Snell, Henning Gieseler, Christopher P. Calderon, Theodore W. Randolph
    Journal of Pharmaceutical Sciences 2024 113 5
  • Morphologically-Directed Raman Spectroscopy as an Analytical Method for Subvisible Particle Characterization in Therapeutic Protein Product Quality
    Minkyung Kim, Youlong Ma, Charudharshini Srinivasan, Thomas O’Connor, Srivalli N. Telikepalli, Dean C. Ripple, Scott Lute, Ashwinkumar Bhirde
    Scientific Reports 2023 13 1
  • Comparison of Protein-like Model Particles Fabricated by Micro 3D Printing to Established Standard Particles
    Ilias Amara, Oliver Germershaus, Christopher Lentes, Steffen Sass, Stephany Mamdjo Youmto, Jan Olaf Stracke, Mirjam Clemens-Hemmelmann, Anacelia Assfalg
    Journal of Pharmaceutical Sciences 2024 113 8
  • Representative training data sets are critical for accurate machine-learning classification of microscopy images of particles formed by lipase-catalyzed polysorbate hydrolysis
    David N. Greenblott, Christopher P. Calderon, Theodore W. Randolph
    Journal of Pharmaceutical Sciences 2025 114 2
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 79 (2)
PDA Journal of Pharmaceutical Science and Technology
Vol. 79, Issue 2
March/April 2025
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Development of Protein-Like Reference Material for Semi-Quantitatively Monitoring Visible Proteinaceous Particles in Biotherapeutics
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Development of Protein-Like Reference Material for Semi-Quantitatively Monitoring Visible Proteinaceous Particles in Biotherapeutics
Srivalli N Telikepalli, Kristen Gonzalez, Sonia Dragulin-Otto, Dean Ripple, Michael J. Carrier, Mariam Khan
PDA Journal of Pharmaceutical Science and Technology Jun 2019, pdajpst.2018.008953; DOI: 10.5731/pdajpst.2018.008953

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Development of Protein-Like Reference Material for Semi-Quantitatively Monitoring Visible Proteinaceous Particles in Biotherapeutics
Srivalli N Telikepalli, Kristen Gonzalez, Sonia Dragulin-Otto, Dean Ripple, Michael J. Carrier, Mariam Khan
PDA Journal of Pharmaceutical Science and Technology Jun 2019, pdajpst.2018.008953; DOI: 10.5731/pdajpst.2018.008953
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Quantitative and Qualitative Evaluation of Microorganism Profile Identified in Bioburden Analysis in a Biopharmaceutical Facility in Brazil: Criteria for Classification and Management of Results
  • Evaluation of Extreme Depyrogenation Conditions on the Surface Hydrolytic Resistance of Glass Containers for Pharmaceutical Use
  • A Holistic Approach for Filling Volume Variability Evaluation and Control with Statistical Tool
Show more Research

Similar Articles

Keywords

  • Ethylene tetrafluoroethylene
  • protein aggregation
  • Protein particle standard
  • Proteinaceous visible particles
  • Proteins
  • stability

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire